Semaglutide has been shown to: Significantly decrease appetite Lower blood sugar levels Enhance insulin secretion Reduced inflammatory marker, C-reactive protein Improve heart, liver, and lung function Neuroprotective effects These products are supplied strictly for laboratory research and development purposes only
10.1373/clinchem.2006.067793 89 SalemH
Lean meats, fish, eggs, Greek yogurt, cottage cheese, and protein supplements become staple foods during GLP-1 therapy
Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal discomfort, typically most pronounced early in treatment
GLP-1 receptor activation enhances insulin secretion in response to meals, suppresses glucagon release (which reduces hepatic glucose production), slows gastric emptying, and promotes satiety